Skip to main content
UniHealth

Doctor search

Shane Paul Dormady, MD

Hematology/Oncology · Los Gatos

NPI 1417024654

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
35
9 carriers
Office
1

Offices

1 location · El Camino Health Medical Network LLC · 202 clinicians in this group

Looking this up.

Hospitals listed: El Camino Health · Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

35 plans · 9 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dormady’s office at (408) 866-4070 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

35 of 35 plans

Plans whose provider directory lists this clinician
Advantage Care (HMO)Align Senior CareListedOct 1, 2026
Premier Care (HMO I-SNP)Align Senior CareListedOct 1, 2026
Senior Care (HMO I-SNP)Align Senior CareListedOct 1, 2026
Alignment Health Advantage PPO (PPO)Alignment Health PlanListedOct 3, 2026
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
Anthem Full Dual Advantage Aligned (HMO D-SNP)Anthem Blue CrossListedOct 3, 2026
Anthem Medicare Advantage (HMO-POS)Anthem Blue CrossListedOct 3, 2026
Anthem Prime (HMO-POS)Anthem Blue Cross Partnership PlanListedOct 3, 2026
Astiva Health C-SNP WOW - NorCal (HMO C-SNP)Astiva HealthListedSep 27, 2026
Astiva Health Premier Plan - NorCal (HMO)Astiva HealthListedSep 27, 2026
Astiva Health Savings Plan - NorCal (HMO)Astiva HealthListedSep 27, 2026
Blue Shield Inspire (HMO)Blue Shield of CaliforniaListedAug 26, 2026
Central Health Classic Care Plan III (HMO)Central Health Medicare PlanListedAug 15, 2026
Central Health Dual Access Plan (HMO D-SNP)Central Health Medicare PlanListedAug 15, 2026
Central Health Embrace Care Plan (HMO C-SNP)Central Health Medicare PlanListed, may be out of dateSep 15, 2025
Central Health Embrace Choice Plan (HMO C-SNP)Central Health Medicare PlanListedAug 15, 2026
Central Health Valor Care Plan (HMO)Central Health Medicare PlanListedAug 15, 2026
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026

California Medical Board record

Licence A87232 · Current

Licensed to practise in California · since 2004 · expires 2027-10-31 · New York University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

3 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
  • Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend it
    Overall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health

Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at El Camino Health
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.291BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.393BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.96 (0.12 to 1.79) · 2,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.02 (0.76 to 1.28)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths167.38 (125.03 to 209.73) · 96 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.6 · 68 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 185 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.8 · 200 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.9 · 814 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths13 · 842 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 361 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.6 · 4,633 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.34) · 11,474 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.1 to 0.45) · 11,626 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.14 (1.39 to 4.9) · 2,814 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2 (0.61 to 3.39) · 1,327 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.11 (0.8 to 3.43) · 2,641 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths9.39 (4.18 to 14.6) · 1,287 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.57 (3.47 to 9.68) · 1,308 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.14 (0.71 to 3.57) · 827 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.6 (0.05 to 1.15) · 9,460 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.5 · 122 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.993No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.706No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.376No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.5 · 218 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.5 · 962 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits3.8 · 200 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-17 · 922 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits18.6 · 860 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.7 · 827 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.1 (4.5 to 8.2) · 313 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits13.4 (10.6 to 16.5) · 313 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.1 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.7 · 237 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.8 (10 to 16.1) · 1,639 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.8 to 1.1) · 1,619 casesNo differentJan 2024 – Dec 2024

What patients said (1,535 patients answered, 22% of those asked)

Patient survey stars by topic at El Camino Health
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information3
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at El Camino Health
Room was "always" clean75%
Nurses "always" communicated well79%
Doctors "always" communicated well81%
Staff "always" explained61%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand75%
Nurses "always" listened carefully76%
Nurses "always" treated them with courtesy and respect87%
"Always" quiet at night47%
"YES", patients would definitely recommend the hospital80%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Good Samaritan Hospital

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Good Samaritan Hospital
Clostridium Difficile (C.Diff)Infections0.337BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.75 (0 to 1.67) · 1,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.84 (0.54 to 1.14)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths143.59 (98.7 to 188.49) · 98 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.7 · 45 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 100 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.7 · 270 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths11.3 · 573 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15.6 · 820 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.5 · 482 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.3 · 3,711 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.12 (0 to 0.3) · 8,866 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.01 to 0.38) · 9,051 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.65 (0.74 to 4.56) · 1,929 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.8 (0.21 to 3.39) · 670 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.33 (0.88 to 3.78) · 1,836 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.73 (0 to 13.46) · 669 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths7.58 (3.96 to 11.19) · 654 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.59 (0.13 to 3.04) · 496 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.27 (0 to 0.87) · 7,373 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.1 · 152 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections1.08No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.542No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.484No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.565No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.8 · 327 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits24.2 · 703 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits61.1 · 289 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits36.3 · 665 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits25.4 · 856 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits19 · 978 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits6.3 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits12.3 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits21.2 · 135 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.8 (10.1 to 18.6) · 129 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.2 (0.9 to 1.5) · 531 casesNo differentJan 2024 – Dec 2024

What patients said (704 patients answered, 24% of those asked)

Patient survey stars by topic at Good Samaritan Hospital
Cleanliness3
Nurse communication3
Doctor communication2
Communication about medicines2
Discharge information3
Overall hospital rating2
Quietness1
Recommend hospital3
Share of patients giving the best answer at Good Samaritan Hospital
Room was "always" clean66%
Nurses "always" communicated well75%
Doctors "always" communicated well71%
Staff "always" explained54%
Yes, staff "did" give patients this information83%
Yes, staff "did" give patients information about help after discharge81%
Doctors "always" explained things so they could understand66%
Doctors "always" listened carefully69%
Doctors "always" treated them with courtesy and respect78%
Patients who gave a rating of "9" or "10" (high)63%
Staff "always" explained new medications68%
Nurses "always" explained things so they could understand69%
Nurses "always" listened carefully73%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night38%
"YES", patients would definitely recommend the hospital67%
Staff "always" explained possible side effects40%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$392,552

Medicare paid this office $392,552 for 805 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)651$232,648$123
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes98$68,923$106
Telephone medical discussion with physician, 21-30 minutes227$50,034$119
New patient visit (60+ min)137$22,175$162
Initial hospital care with moderate level of medical decision making at least 75 minutes53$10,475$148
See all 7 services
Every Original Medicare service billed
Long return visit (40+ min)651$232,648$123
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes98$68,923$106
Telephone medical discussion with physician, 21-30 minutes227$50,034$119
New patient visit (60+ min)137$22,175$162
Initial hospital care with moderate level of medical decision making at least 75 minutes53$10,475$148
Long return visit (40+ min)19$2,819$128
Hospital discharge day management, more than 30 minutes12$1,885$105

Who their Medicare patients are

805 Original Medicare patients in 2024. Average age 78 · Under 65 1% · 85 and older 22% · Women 53% · Also on Medicaid 9% · Health risk score 1.57. At or below the middle of the specialty; the typical hematology-oncology clinician is at 2.04.

Conditions among them: High blood pressure 70% · Cancer 58% · Coronary heart disease 28% · Diabetes 25% · Chronic kidney disease 22% · Atrial fibrillation 21% · Heart failure 16% · Depression 15% · COPD 10% · Stroke 10% · Dementia 8%.

The office billed $1,862,460, Medicare allowed $520,544 and paid $392,552; for 3,261 services of 11 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20248053,261781.57$1,862,460$392,552
20237422,751771.59$1,612,774$328,551
20226792,434771.52$1,469,445$296,379
20216512,743771.65$1,457,845$327,722
20206352,740771.85$1,158,261$234,397
20196613,095771.84$1,299,108$275,333
20185151,508771.71$649,838$157,946
20177092,611771.75$1,031,358$299,773
20168314,121771.80$1,260,217$375,506
20158904,709771.86$1,366,480$404,163
20149275,210771.77$1,515,106$347,899
20138294,582771.82$970,061$357,780

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 9 services

Original Medicare services billed in 2023
Long return visit (40+ min)617$215,964$121
Telephone medical discussion with physician, 21-30 minutes201$41,597$118
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes73$39,747$108
New patient visit (60+ min)101$16,470$163
Initial hospital care with moderate level of medical decision making at least 75 minutes30$4,814$155
Long return visit (40+ min)15$2,490$113
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes14$2,401$73
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes14$1,669$119
Hospital discharge day management, more than 30 minutes12$1,281$107

2022: 7 services

Original Medicare services billed in 2022
Long return visit (40+ min)590$228,195$124
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes66$21,110$93
Telephone medical discussion with physician, 21-30 minutes109$18,761$113
New patient visit (60+ min)104$16,362$157
Initial hospital care with moderate level of medical decision making at least 75 minutes25$4,892$181
Long return visit (40+ min)14$3,492$145
Hospital discharge day management, more than 30 minutes14$1,473$98

2021: 8 services

Original Medicare services billed in 2021
Long return visit (40+ min)527$230,652$130
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes83$28,059$95
Return visit (30+ min)219$24,672$72
Telephone medical discussion with physician, 21-30 minutes94$18,649$120
New patient visit (60+ min)91$15,312$168
Initial hospital care with moderate level of medical decision making at least 75 minutes23$5,482$177
Hospital discharge day management, more than 30 minutes15$2,344$94
Biopsy and aspiration of bone marrow sample for diagnosis13$1,097$69

2020: 9 services

Original Medicare services billed in 2020
Long return visit (40+ min)311$81,580$96
Return visit (30+ min)443$72,126$67
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes85$31,563$94
Telephone medical discussion with physician, 21-30 minutes86$14,913$106
New patient visit (60+ min)79$12,252$155
Initial hospital care with moderate level of medical decision making at least 75 minutes36$10,162$181
Short return visit (20+ min)107$6,410$46
Hospital discharge day management, more than 30 minutes21$3,176$93
Biopsy and aspiration of bone marrow sample for diagnosis16$1,152$68

2019: 10 services

Original Medicare services billed in 2019
Long return visit (40+ min)358$111,722$99
Return visit (30+ min)464$75,344$69
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes135$57,868$95
New patient visit (60+ min)84$12,484$149
Initial hospital care with moderate level of medical decision making at least 75 minutes25$4,874$181
Return visit (30+ min)40$3,044$76
Long return visit (40+ min)19$2,505$119
Follow-up observation care per day, typically 35 minutes15$2,202$96
Hospital discharge day management, more than 30 minutes13$1,394$100
Biopsy and aspiration of bone marrow sample for diagnosis14$1,026$73

2018: 5 services

Original Medicare services billed in 2018
Long return visit (40+ min)251$63,732$122
Return visit (30+ min)360$59,423$91
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes41$22,158$91
New patient visit (60+ min)39$7,207$185
Initial hospital care with moderate level of medical decision making at least 75 minutes19$3,882$176

2017: 6 services

Original Medicare services billed in 2017
Long return visit (40+ min)471$171,448$133
Return visit (30+ min)409$69,324$98
Short return visit (20+ min)170$21,465$67
New patient visit (60+ min)94$17,588$187
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes56$16,452$93
Initial hospital care with moderate level of medical decision making at least 75 minutes11$2,357$181

2016: 8 services

Original Medicare services billed in 2016
Long return visit (40+ min)478$150,442$124
Short return visit (20+ min)439$105,052$63
Return visit (30+ min)444$70,215$90
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes69$21,575$89
New patient visit (60+ min)105$18,562$177
Initial hospital care with moderate level of medical decision making at least 75 minutes19$4,027$168
Biopsy of bone marrow12$1,932$161
Aspiration of bone marrow sample for diagnosis12$953$79

2015: 12 services

Original Medicare services billed in 2015
Return visit (30+ min)676$164,853$97
Short return visit (20+ min)313$77,981$66
Long return visit (40+ min)221$51,980$130
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes90$35,116$90
New patient visit (60+ min)127$22,883$180
Return visit (30+ min)306$20,592$49
Initial hospital care with moderate level of medical decision making at least 75 minutes38$7,269$173
Short return visit (20+ min)100$4,987$32
New patient visit (60+ min)29$3,588$124
Long return visit (40+ min)36$3,101$84
Biopsy of bone marrow16$2,589$162
Aspiration of bone marrow sample for diagnosis17$1,436$84

2014: 10 services

Original Medicare services billed in 2014
Return visit (30+ min)709$155,414$65
Short return visit (20+ min)393$62,830$42
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes122$42,646$91
Long return visit (40+ min)181$29,416$93
New patient visit (60+ min)203$28,556$141
Initial hospital care with moderate level of medical decision making at least 75 minutes76$13,311$173
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes46$10,296$63
Aspiration of bone marrow sample for diagnosis25$1,186$46
Biopsy of bone marrow22$1,112$51
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service21$165$8

2013: 12 services

Original Medicare services billed in 2013
Return visit (30+ min)508$133,455$95
Return visit (30+ min)447$59,126$66
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes117$34,102$88
Short return visit (20+ min)235$29,625$63
Short return visit (20+ min)272$24,889$43
New patient visit (60+ min)93$16,804$181
New patient visit (60+ min)85$12,078$142
Long return visit (40+ min)73$10,051$93
Initial hospital care with moderate level of medical decision making at least 75 minutes54$9,809$172
Long return visit (40+ min)46$6,808$131
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes47$5,412$61
Aspiration of bone marrow sample for diagnosis13$625$45

Medicaid work

$0 in 2024

Medicaid paid $0 for 16 billed services this clinician did in 2024, up to 13 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Long return visit (40+ min)16$0
Medicaid work by year
202416113$0
202320117$46
202033114$101
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Long return visit (40+ min)20$46

2020

Largest Medicaid services in 2020
Long return visit (40+ min)33$101

Drugs they prescribed that Part D paid

$7,853,370

Pharmacies billed $7,853,370 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 7% of their Part D prescriptions (171 of 2,352) in 2024. Above the middle of the specialty; the typical hematology-oncology clinician is at 5%. Long-acting opioids: 33% of their opioid prescriptions.

1,558 generic and fewer than 11 brand-name prescriptions · $7,853,370 in drug cost · 55 antibiotic prescriptions to 35 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Erleada62$857,084$13,824
Xtandi59$741,892$12,574
Brukinsa48$690,015$14,375
Lenalidomide50$682,431$13,649
Imbruvica42$673,972$16,047
See all 62 drugs
Every Part D drug this clinician prescribed
ErleadaNone62$857,084$13,824
XtandiNone59$741,892$12,574
BrukinsaNone48$690,015$14,375
LenalidomideNone50$682,431$13,649
ImbruvicaNone42$673,972$16,047
TagrissoNone30$508,997$16,967
IbranceNone26$349,381$13,438
PomalystNone18$343,347$19,075
LynparzaNone32$328,511$10,266
VerzenioNone22$322,398$14,654
NubeqaNone20$271,534$13,577
JakafiNone14$238,329$17,024
OrgovyxNone76$206,062$2,711
BraftoviNone11$203,685$18,517
CabometyxNone17$192,418$11,319
Sunitinib MalateNone16$103,824$6,489
EliquisNone75$85,245$1,137
Gamunex-CImmune globulin12$54,813$4,568
XareltoNone54$46,083$853
ProcritNone11$29,221$2,656
ErlotinibNone21$23,398$1,114
Abiraterone AcetateNone18$17,294$961
Imatinib MesylateNone25$3,493$140
Megestrol AcetateNone34$3,260$96
ExemestaneNone25$2,696$108
AnastrozoleNone96$2,424$25
Hydrocodone-AcetaminophenNone56$1,206$22
HydroxyureaNone41$1,181$29
DexamethasoneNone36$1,029$29
PantoprazoleNone46$939$20
HydromorphoneNone27$759$28
FentanylNone11$758$69
Potassium ChlorideNone50$711$14
BicalutamideNone22$687$31
GabapentinNone70$663$9
MethadoneNone34$541$16
OndansetronNone28$514$18
LorazepamNone68$483$7
PrednisoneNone71$443$6
Tamoxifen CitrateNone15$404$27
DutasterideNone23$403$18
RosuvastatinNone41$396$10
FluconazoleNone12$361$30
OxycodoneNone21$353$17
AlendronateNone20$345$17
LevothyroxineNone66$295$4
Triamcinolone AcetonideNone26$270$10
TemazepamNone16$196$12
Amlodipine BesylateNone11$189$17
DiazepamNone17$174$10
AtorvastatinNone21$174$8
LosartanNone24$169$7
TamsulosinNone21$159$8
Diphenoxylate-AtropineNone11$154$14
MetforminNone16$144$9
ZolpidemNone30$126$4
FamotidineNone13$119$9
Citalopram HbrNone25$102$4
AzithromycinNone12$84$7
CiprofloxacinNone13$75$6
Venlafaxine Hcl ErNone23$56$2
MetoclopramideNone11$40$4

Year by year

Part D prescribing by year
20242,3523667% (171)None$7,853,370
20238942544% (34)None$1,584,587
20226001893% (19)None$1,204,804
20216971844% (28)None$1,304,706
20207361815% (39)17%$807,028
20198261984% (34)22%$1,159,309
20187441685% (34)19%$802,136
20171,2832317% (91)None$899,304
20161,4392486% (81)None$647,650
20151,7092457% (127)None$1,466,770
20141,84725312% (228)None$1,601,644
20132,05723414% (289)None$1,235,544

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 26 drugs

Part D drugs prescribed in 2023
Erleada16$231,029$14,439
Imbruvica14$223,428$15,959
Tagrisso11$205,555$18,687
Revlimid11$200,896$18,263
Eliquis52$54,727$1,052
Xarelto11$12,376$1,125
Megestrol Acetate32$3,356$105
Anastrozole49$1,923$39
Hydroxyurea29$1,130$39
Dexamethasone21$916$44
Tamoxifen Citrate16$818$51
Potassium Chloride23$688$30
Diphenoxylate-Atropine18$509$28
Pantoprazole16$342$21
Prednisone30$313$10
Hydrocodone-Acetaminophen15$294$20
Lorazepam21$293$14
Rosuvastatin21$267$13
Levothyroxine15$252$17
Venlafaxine Hcl Er11$236$21
Gabapentin26$228$9
Diazepam13$212$16
Ondansetron14$173$12
Zolpidem14$87$6
Atorvastatin13$78$6
Furosemide11$44$4

2022: 15 drugs

Part D drugs prescribed in 2022
Revlimid25$563,193$22,528
Erleada16$197,376$12,336
Imbruvica11$164,654$14,969
Eliquis16$13,135$821
Megestrol Acetate19$2,261$119
Anastrozole40$1,228$31
Bicalutamide22$959$44
Diphenoxylate-Atropine14$372$27
Potassium Chloride12$343$29
Pantoprazole14$258$18
Prednisone23$217$9
Temazepam13$189$15
Citalopram Hbr17$118$7
Gabapentin11$112$10
Lorazepam13$78$6

2021: 20 drugs

Part D drugs prescribed in 2021
Revlimid19$414,413$21,811
Imbruvica26$328,761$12,645
Erleada13$97,975$7,537
Xarelto12$16,199$1,350
Eliquis13$9,781$752
Rosuvastatin23$1,256$55
Anastrozole23$1,114$48
Bicalutamide20$991$50
Dexamethasone17$649$38
Gabapentin33$616$19
Diazepam14$376$27
Potassium Chloride14$218$16
Ondansetron Odt14$203$15
Metoprolol11$184$17
Pantoprazole16$174$11
Prednisone21$173$8
Ciprofloxacin15$141$9
Temazepam15$118$8
Metformin14$78$6
Zolpidem17$73$4

2020: 23 drugs

Part D drugs prescribed in 2020
Inlyta14$229,547$16,396
Imbruvica14$126,352$9,025
Erlotinib16$66,546$4,159
Xarelto15$20,540$1,369
Eliquis15$11,108$741
Megestrol Acetate15$4,790$319
Bicalutamide21$1,697$81
Hydroxyurea24$1,292$54
Anastrozole23$1,054$46
Tamoxifen Citrate13$742$57
Dexamethasone16$602$38
Letrozole15$432$29
Hydrocodone-Acetaminophen15$402$27
Pantoprazole16$401$25
Gabapentin28$362$13
Tamsulosin24$329$14
Levothyroxine17$274$16
Venlafaxine Hcl Er13$272$21
Diazepam12$271$23
Temazepam11$150$14
Prednisone23$137$6
Citalopram Hbr13$41$3
Simvastatin15$36$2

2019: 21 drugs

Part D drugs prescribed in 2019
Revlimid34$654,238$19,242
Imbruvica17$235,728$13,866
Eliquis51$28,264$554
Exemestane34$13,265$390
Enoxaparin12$4,968$414
Anastrozole60$2,085$35
Bicalutamide29$1,652$57
Hydroxyurea18$1,244$69
Letrozole12$657$55
Gabapentin24$501$21
Hydrocodone-Acetaminophen19$482$25
Dexamethasone13$455$35
Tamsulosin24$448$19
Pantoprazole31$392$13
Potassium Chloride16$355$22
Prednisone36$265$7
Lorazepam12$244$20
Triamcinolone Acetonide14$167$12
Levothyroxine21$116$6
Citalopram Hbr15$63$4
Simvastatin12$55$5

2018: 23 drugs

Part D drugs prescribed in 2018
Revlimid22$367,483$16,704
Imbruvica16$204,362$12,773
Eliquis32$18,946$592
Xarelto20$15,644$782
Exemestane47$14,785$315
Enoxaparin11$5,129$466
Anastrozole98$2,021$21
Gabapentin22$1,200$55
Hydroxyurea20$872$44
Bicalutamide19$782$41
Dutasteride12$569$47
Ondansetron13$454$35
Potassium Chloride16$435$27
Pantoprazole19$300$16
Alendronate17$181$11
Tamsulosin14$178$13
Triamcinolone Acetonide13$129$10
Lorazepam12$123$10
Prednisone11$106$10
Losartan11$101$9
Levothyroxine18$97$5
Simvastatin11$58$5
Citalopram Hbr13$51$4

2017: 36 drugs

Part D drugs prescribed in 2017
Imbruvica37$289,032$7,812
Revlimid13$202,341$15,565
Tarceva14$141,673$10,120
Exemestane56$29,502$527
Xarelto45$26,717$594
Eliquis26$13,100$504
Pradaxa14$5,929$424
Anastrozole157$3,945$25
Bicalutamide56$2,394$43
Tamoxifen Citrate31$1,018$33
Hydroxyurea23$998$43
Gabapentin18$997$55
Ondansetron24$809$34
Dutasteride13$786$60
Pantoprazole32$502$16
Potassium Chloride20$414$21
Levothyroxine30$350$12
Letrozole12$294$25
Lorazepam45$286$6
Hydrocodone-Acetaminophen17$276$16
Alendronate31$264$9
Zolpidem30$259$9
Triamcinolone Acetonide23$246$11
Hydromorphone12$238$20
Doxazosin Mesylate11$211$19
Tamsulosin14$204$15
Metformin22$198$9
Citalopram Hbr11$191$17
Diazepam12$183$15
Temazepam26$179$7
Prednisone19$167$9
Alprazolam23$144$6
Promethazine11$143$13
Tramadol34$121$4
Methadone11$78$7
Metoclopramide12$49$4

2016: 28 drugs

Part D drugs prescribed in 2016
Tarceva26$203,578$7,830
Xarelto65$25,827$397
Exemestane70$25,586$366
Pradaxa13$5,822$448
Anastrozole174$4,027$23
Bicalutamide61$1,734$28
Tamoxifen Citrate51$1,589$31
Megestrol Acetate18$1,560$87
Hydroxyurea24$993$41
Hydrocodone-Acetaminophen25$955$38
Pantoprazole50$910$18
Lorazepam63$782$12
Gabapentin20$769$38
Ondansetron20$618$31
Potassium Chloride31$491$16
Letrozole24$440$18
Temazepam28$338$12
Diazepam13$333$26
Dexamethasone18$331$18
Metformin32$326$10
Alendronate53$272$5
Zolpidem23$266$12
Tamsulosin21$256$12
Metoclopramide24$250$10
Omeprazole17$130$8
Tramadol28$112$4
Hydrochlorothiazide20$62$3
Lisinopril12$45$4

2015: 49 drugs

Part D drugs prescribed in 2015
Tarceva54$405,975$7,518
Afinitor25$264,187$10,567
Ibrance12$118,657$9,888
Xtandi13$115,409$8,878
Zytiga19$93,218$4,906
Gleevec12$54,627$4,552
Exemestane74$24,926$337
Xarelto59$22,486$381
Oxycontin27$13,299$493
Arimidex11$7,145$650
Pradaxa13$6,979$537
Leukeran12$5,915$493
Symbicort12$3,316$276
Anastrozole170$3,093$18
Bicalutamide59$1,981$34
Diphenoxylate-Atropine21$1,304$62
Tamoxifen Citrate30$1,136$38
Hydroxyurea19$825$43
Potassium Chloride58$798$14
Gabapentin17$797$47
Hydrocodone-Acetaminophen17$631$37
Hydromorphone12$604$50
Oxycodone20$585$29
Pantoprazole37$566$15
Diazepam33$558$17
Megestrol Acetate12$549$46
Lorazepam55$506$9
Ondansetron13$454$35
Zolpidem31$452$15
Tramadol28$379$14
Nadolol11$350$32
Dexamethasone33$342$10
Triamcinolone Acetonide14$326$23
Prednisone31$313$10
Metformin23$292$13
Levofloxacin16$286$18
Alendronate39$264$7
Metoclopramide24$250$10
Azithromycin19$239$13
Omeprazole26$237$9
Letrozole24$235$10
Methadone11$189$17
Tamsulosin13$179$14
Levothyroxine13$162$12
Amlodipine Besylate11$93$8
Hydrochlorothiazide23$87$4
Temazepam12$87$7
Ciprofloxacin14$86$6
Furosemide20$46$2

2014: 55 drugs

Part D drugs prescribed in 2014
Tarceva49$334,737$6,831
Afinitor32$304,599$9,519
Revlimid18$214,773$11,932
Inlyta19$198,242$10,434
Xtandi22$181,677$8,258
Gleevec14$67,296$4,807
Oxycontin27$20,466$758
Xarelto63$19,542$310
Exemestane55$18,113$329
Anastrozole176$5,763$33
Lyrica13$4,899$377
Celebrex12$3,371$281
Combivent Respimat11$3,000$273
Hydrocodone-Acetaminophen70$2,334$33
Lexapro11$2,100$191
Potassium Chloride47$1,832$39
Tamoxifen Citrate41$1,152$28
Oxycodone32$1,095$34
Gabapentin44$1,049$24
Hydroxyurea16$741$46
Pantoprazole27$705$26
Valsartan-Hydrochlorothiazide12$652$54
Bicalutamide28$578$21
Hydromorphone22$548$25
Lorazepam55$528$10
Valacyclovir14$473$34
Oxycodone-Acetaminophen16$465$29
Diazepam32$438$14
Prednisone41$383$9
Venlafaxine Hcl Er20$371$19
Ondansetron16$351$22
Alendronate34$328$10
Tramadol24$281$12
Metformin20$266$13
Zolpidem42$266$6
Dexamethasone32$265$8
Amox Tr-Potassium Clavulanate18$262$15
Diphenoxylate-Atropine12$244$20
Omeprazole15$230$15
Levofloxacin18$223$12
Ciprofloxacin30$191$6
Mirtazapine18$189$10
Azithromycin23$183$8
Temazepam30$180$6
Amitriptyline12$165$14
Furosemide28$149$5
Letrozole13$148$11
Hydrochlorothiazide13$111$9
Amlodipine Besylate19$107$6
Propranolol13$103$8
Paroxetine11$92$8
Methadone17$87$5
Citalopram Hbr11$72$7
Doxepin11$69$6
Atenolol12$44$4

2013: 51 drugs

Part D drugs prescribed in 2013
Tarceva41$210,491$5,134
Xtandi25$158,836$6,353
Revlimid13$157,188$12,091
Afinitor15$113,215$7,548
Enoxaparin24$55,814$2,326
Erivedge11$47,354$4,305
Oxycontin52$31,734$610
Xarelto43$11,294$263
Exemestane35$10,583$302
Anastrozole177$7,311$41
Pradaxa18$4,697$261
Travasol18$4,693$261
Lyrica11$3,807$346
Dronabinol11$2,785$253
Oxycodone51$2,540$50
Hydromorphone42$1,961$47
Potassium Chloride45$1,853$41
Hydrocodone-Acetaminophen75$1,630$22
Intralipid21$1,572$75
Valsartan-Hydrochlorothiazide18$1,455$81
Gabapentin36$1,331$37
Fentanyl14$1,320$94
Lorazepam100$756$8
Pantoprazole38$752$20
Ondansetron36$715$20
Bicalutamide13$693$53
Tamoxifen Citrate39$645$17
Hydroxyurea13$585$45
Lidocaine-Prilocaine16$558$35
Omeprazole16$552$34
Escitalopram14$495$35
Diazepam40$424$11
Alendronate33$378$11
Zolpidem51$369$7
Metformin22$349$16
Letrozole13$339$26
Azithromycin27$288$11
Dexamethasone43$267$6
Amlodipine Besylate18$244$14
Oxycodone-Acetaminophen16$243$15
Mirtazapine20$232$12
Venlafaxine Hcl Er22$231$10
Temazepam16$203$13
Furosemide31$187$6
Levofloxacin15$169$11
Prednisone32$167$5
Levothyroxine15$141$9
Warfarin17$135$8
Ciprofloxacin21$122$6
Hydrochlorothiazide11$115$10
Atenolol13$75$6

Money from drug and device companies

$1,395 in 2025

Industry payments by year
202547$1,000$1,395
202411None$145
202322None$41
202212None$34
202111None$12
20201214None$293
20191863None$1,224

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Caris MPIMi Cancer Seek$1,233
4 payments
  • Meals for Mi Cancer Seek · 2025-08-13 · $106
  • Meals for Mi Cancer Seek · 2025-06-13 · $123
  • Consulting · 2025-05-20 · $1,000
  • Meals for Mi Cancer Seek · 2025-05-14 · $5
AstraZeneca Pharmaceuticals LPLynparza$106
1 payment
  • Meals for Lynparza · 2025-06-12 · $106
PfizerIbrance$31
1 payment
  • Education for Ibrance · 2025-07-10 · $31
Daiichi SankyoEnhertu$26
1 payment
  • Meals for Enhertu · 2025-02-14 · $26
See all 7 published payments
Every published payment
Caris MPIMeals · 2025-08-13Mi Cancer Seek$106
PfizerEducation · 2025-07-10Ibrance$31
Caris MPIMeals · 2025-06-13Mi Cancer Seek$123
AstraZeneca Pharmaceuticals LPMeals · 2025-06-12Lynparza$106
Caris MPIConsulting · 2025-05-20None$1,000
Caris MPIMeals · 2025-05-14Mi Cancer Seek$5
Daiichi SankyoMeals · 2025-02-14Enhertu$26
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $145

Payments by company in 2024
ADC Therapeutics AmericaNone$145
1 payment
  • Meals · 2024-12-11 · $145

2023: $41

Payments by company in 2023
PfizerIbrance$25
1 payment
  • Education for Ibrance · 2023-07-27 · $25
Lilly USAVerzenio$16
1 payment
  • Meals for Verzenio · 2023-10-02 · $16

2022: $34

Payments by company in 2022
Novartis PharmaceuticalsNone$34
2 payments
  • Meals · 2022-10-27 · $22
  • Meals · 2022-07-15 · $12

2021: $12

Payments by company in 2021
Gilead SciencesNone$12
1 payment
  • Education · 2021-06-01 · $12

2020: $293

Payments by company in 2020
Lilly USAAlimta$46
2 payments
  • Meals for Alimta · 2020-02-25 · $24
  • Meals for Alimta · 2020-02-10 · $22
AstraZeneca Pharmaceuticals LPLynparza$36
2 payments
  • Meals for Lynparza · 2020-03-12 · $21
  • Meals for Imfinzi · 2020-01-15 · $15
EisaiLenvima$27
1 payment
  • Meals for Lenvima · 2020-02-26 · $27
Blueprint MedicinesAyvakit$25
1 payment
  • Meals for Ayvakit · 2020-03-16 · $25
SeagenPadcev$25
1 payment
  • Meals for Padcev · 2020-01-29 · $25
IncyteJakafi$23
1 payment
  • Meals for Jakafi · 2020-03-10 · $23
Bayer HealthCare PharmaceuticalsNubeqa$22
1 payment
  • Meals for Nubeqa · 2020-02-12 · $22
Merck Sharp & DohmeKeytruda$20
1 payment
  • Meals for Keytruda · 2020-02-19 · $20
Novartis PharmaceuticalsTasigna$20
1 payment
  • Meals for Tasigna · 2020-01-27 · $20
Puma BiotechnologyNerlynx$17
1 payment
  • Meals for Nerlynx · 2020-02-03 · $17
CelgeneRevlimid$17
1 payment
  • Meals for Revlimid · 2020-01-09 · $17
Foundation MedicineFoundationone$16
1 payment
  • Meals for Foundationone · 2020-01-28 · $16

2019: $1,224

Payments by company in 2019
Lilly USAAlimta$151
8 payments
  • Meals for Erbitux · 2019-10-23 · $23
  • Meals for Alimta · 2019-09-19 · $20
  • Meals for Verzenio · 2019-08-28 · $15
  • Meals for Alimta · 2019-07-10 · $20
  • Meals for Alimta · 2019-06-12 · $19
  • Meals for Erbitux · 2019-05-15 · $13
  • Meals for Alimta · 2019-03-27 · $18
  • Meals for Alimta · 2019-02-27 · $24
Merck Sharp & DohmeKeytruda$143
8 payments
  • Meals for Keytruda · 2019-12-18 · $20
  • Meals for Keytruda · 2019-11-20 · $14
  • Meals for Keytruda · 2019-09-25 · $19
  • Meals for Keytruda · 2019-07-15 · $19
  • Meals for Keytruda · 2019-07-01 · $15
  • Meals for Lynparza · 2019-05-15 · $17
  • Meals for Keytruda · 2019-03-18 · $19
  • Meals for Keytruda · 2019-02-06 · $20
Novartis PharmaceuticalsVotrient$139
7 payments
  • Meals for Votrient · 2019-09-09 · $22
  • Meals for Tasigna · 2019-07-31 · $17
  • Meals for Piqray · 2019-07-22 · $24
  • Meals for Tasigna · 2019-06-17 · $17
  • Meals for Votrient · 2019-06-03 · $20
  • Meals for Promacta · 2019-04-10 · $18
  • Meals for Promacta · 2019-02-20 · $23
E.R. Squibb & Sons L.L.C.Empliciti$108
6 payments
  • Meals for Opdivo · 2019-09-30 · $17
  • Meals for Empliciti · 2019-06-26 · $16
  • Meals for Opdivo · 2019-05-13 · $21
  • Meals · 2019-04-03 · $15
  • Meals for Empliciti · 2019-03-27 · $22
  • Meals for Empliciti · 2019-01-16 · $18
Takeda Pharmaceuticals U.S.A.None$107
4 payments
  • Meals · 2019-12-09 · $30
  • Meals · 2019-09-04 · $26
  • Meals · 2019-05-01 · $28
  • Meals · 2019-01-30 · $24
Bayer HealthCare PharmaceuticalsXofigo$74
4 payments
  • Meals for Nubeqa · 2019-12-11 · $18
  • Meals for Nubeqa · 2019-08-12 · $17
  • Meals for Xofigo · 2019-03-20 · $17
  • Meals for Xofigo · 2019-01-10 · $22
PfizerIbrance$70
4 payments
  • Meals for Xalkori · 2019-11-04 · $20
  • Meals for Xtandi · 2019-10-16 · $24
  • Meals for Ibrance · 2019-03-07 · $12
  • Meals for Ibrance · 2019-02-11 · $14
Janssen BiotechErleada$54
2 payments
  • Meals for Darzalex · 2019-03-13 · $24
  • Meals for Erleada · 2019-02-12 · $30
AmgenNplate$53
2 payments
  • Meals for Kanjinti · 2019-10-23 · $23
  • Meals for Nplate · 2019-02-25 · $29
IncyteJakafi$52
3 payments
  • Meals for Jakafi · 2019-11-18 · $16
  • Meals for Jakafi · 2019-08-16 · $14
  • Meals for Jakafi · 2019-03-12 · $22
Rigel PharmaceuticalsTavalisse$51
2 payments
  • Meals for Tavalisse · 2019-08-07 · $25
  • Meals for Tavalisse · 2019-05-29 · $26
CelgeneRevlimid$49
3 payments
  • Meals for Revlimid · 2019-12-05 · $18
  • Meals for Revlimid · 2019-09-12 · $15
  • Meals for Revlimid · 2019-04-02 · $16
EMD SeronoBavencio$46
3 payments
  • Meals for Bavencio · 2019-07-17 · $18
  • Meals for Bavencio · 2019-06-05 · $14
  • Meals for Bavencio · 2019-05-22 · $13
Seattle GeneticsAdcetris$42
2 payments
  • Meals · 2019-10-07 · $30
  • Education for Adcetris · 2019-03-13 · $12
AstraZeneca Pharmaceuticals LPLynparza$38
2 payments
  • Meals for Imfinzi · 2019-10-09 · $17
  • Meals for Lynparza · 2019-08-19 · $21
TesaroZejula$23
1 payment
  • Meals for Zejula · 2019-04-24 · $23
Foundation MedicineFoundationone$13
1 payment
  • Meals for Foundationone · 2019-08-05 · $13
Clovis OncologyRubraca$12
1 payment
  • Meals for Rubraca · 2019-12-02 · $12

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Amgen Inc. · Expanded Access Use of Imdelltra in A 91-Year-Old Patient Who Was Diagnosed With Dll3+ Mixed Adenocarcinoma and High Grade Neuroendocrine Small Cell Carcinoma of the Prostate · 2025Their institution$183,315
Amgen Inc. · Amg 160 Combo in Prostate Cancer 20180101 · 2024Their institution$41,499
Amgen Inc. · Amg 160 Combo in Prostate Cancer 20180101 · 2021Their institution$7,604
Amgen Inc. · Amg 160 Combo in Prostate Cancer 20180101 · 2022Their institution$6,530

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
83.6 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1417024654
Licence
CA A87232California A87232: Current · expires 2027-10-31
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Medicaid ID
CA 00A872320
Taxonomy
Medical oncology (207RX0202X)
Mailing address
2505 Hospital Dr, Mountain View, CA, 94040
NPI first listed
2006-11-30
NPI last updated
2026-04-10
NPI record certified
2026-04-10

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 2505 Hospital Dr, Mountain View, CA, 94040